Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
98.1M
-
Shares change
-
+13M
-
Total reported value, excl. options
-
$629M
-
Value change
-
+$109M
-
Put/Call ratio
-
0.63
-
Number of buys
-
64
-
Number of sells
-
-51
-
Price
-
$6.42
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2022
145 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2022.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98.1M shares
of 170M outstanding shares and own 57.54% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (18.6M shares), FEDERATED HERMES, INC. (18.5M shares), JANUS HENDERSON GROUP PLC (11.2M shares), VANGUARD GROUP INC (6.61M shares), STATE STREET CORP (3.73M shares), Eversept Partners, LP (1.94M shares), GEODE CAPITAL MANAGEMENT, LLC (1.51M shares), Point72 Asset Management, L.P. (939K shares), and Kynam Capital Management, LP (773K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.